826 related articles for article (PubMed ID: 17498878)
41. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
42. Deficiency of CARD8 is associated with increased Alzheimer's disease risk in women.
Fontalba A; Gutiérrez O; Llorca J; Mateo I; Berciano J; Fernández-Luna JL; Combarros O
Dement Geriatr Cogn Disord; 2008; 26(3):247-50. PubMed ID: 18841008
[TBL] [Abstract][Full Text] [Related]
43. CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.
Kester MI; Blankenstein MA; Bouwman FH; van Elk EJ; Scheltens P; van der Flier WM
J Alzheimers Dis; 2009; 16(3):601-7. PubMed ID: 19276554
[TBL] [Abstract][Full Text] [Related]
44. [Apolipoprotein E gene polymorphisms and Alzheimer disease].
Chen D; Zhang JW; Zhang ZX; Zhao HL; Li XQ; Wu YN; Qu QM
Yi Chuan Xue Bao; 2003 Dec; 30(12):1167-70. PubMed ID: 14986436
[TBL] [Abstract][Full Text] [Related]
45. ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G>A and 1882G>A) with Alzheimer's disease.
Ahn Jo S; Ahn K; Kim JH; Kang BH; Kim E; Jo I; Kim DK
Clin Chim Acta; 2006 Jun; 368(1-2):179-82. PubMed ID: 16480703
[TBL] [Abstract][Full Text] [Related]
46. Association analysis of the paraoxonase-1 gene with Alzheimer's disease.
Cellini E; Tedde A; Bagnoli S; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2006 Nov; 408(3):199-202. PubMed ID: 16996683
[TBL] [Abstract][Full Text] [Related]
47. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
[TBL] [Abstract][Full Text] [Related]
48. -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein.
Smach MA; Charfeddine B; Othman LB; Lammouchi T; Ltaief A; Nafati S; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2010 Mar; 472(2):139-42. PubMed ID: 20138124
[TBL] [Abstract][Full Text] [Related]
49. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population.
Klimkowicz-Mrowiec A; Marona M; Wołkow P; Maruszak A; Styczynska M; Barcikowska M; Zekanowski C; Szczudlik A; Slowik A
Dement Geriatr Cogn Disord; 2009; 28(5):461-4. PubMed ID: 19940477
[TBL] [Abstract][Full Text] [Related]
51. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
[TBL] [Abstract][Full Text] [Related]
52. APOE dependent-association of PPAR-γ genetic variants with Alzheimer's disease risk.
Combarros O; Rodríguez-Rodríguez E; Mateo I; Vázquez-Higuera JL; Infante J; Berciano J; Sánchez-Juan P
Neurobiol Aging; 2011 Mar; 32(3):547.e1-6. PubMed ID: 19660836
[TBL] [Abstract][Full Text] [Related]
53. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease.
Wang X; DeKosky ST; Luedecking-Zimmer E; Ganguli M; Kamboh MI
Hum Genet; 2002 Apr; 110(4):356-65. PubMed ID: 11941486
[TBL] [Abstract][Full Text] [Related]
54. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.
Varges D; Jung K; Gawinecka J; Heinemann U; Schmitz M; von Ahsen N; Krasnianski A; Armstrong VW; Zerr I
J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024
[TBL] [Abstract][Full Text] [Related]
55. [Association between apolipoprotein E polymorphism and Alzheimer's disease: A population-based study in Guangzhou, China].
Lai S; Chen Y; Wen Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):202-4. PubMed ID: 11860878
[TBL] [Abstract][Full Text] [Related]
56. An observational study on the influence of the APOE-epsilon4 allele on the correlation between 'free' copper toxicosis and EEG activity in Alzheimer disease.
Zappasodi F; Salustri C; Babiloni C; Cassetta E; Del Percio C; Ercolani M; Rossini PM; Squitti R
Brain Res; 2008 Jun; 1215():183-9. PubMed ID: 18486114
[TBL] [Abstract][Full Text] [Related]
57. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
[TBL] [Abstract][Full Text] [Related]
58. [The relation between alpha1-antichymotrypsin gene polymorphism and epsilon4 allele of apolipoprotein E gene in Alzheimer disease in Chinese].
Tang G; Jiang S; Gu N; Jin T; Lin S; Qian Y; Wang D; Zhang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Apr; 16(2):94-6. PubMed ID: 10194255
[TBL] [Abstract][Full Text] [Related]
59. Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer disease.
Blesa R; Aguilar M; Casanova JP; Boada M; Martínez S; Alom J; de la Hoz CH; Sancho J; Fernández O; Gil-Neciga E; Massó JF
Alzheimer Dis Assoc Disord; 2006; 20(4):248-54. PubMed ID: 17132969
[TBL] [Abstract][Full Text] [Related]
60. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.
Choi SH; Kim SY; Na HR; Kim BK; Yang DW; Kwon JC; Park MY
Dement Geriatr Cogn Disord; 2008; 25(5):445-50. PubMed ID: 18401173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
